Larrinaga, G.; Valdivia, A.; Arrieta-Aguirre, I.; Solano-Iturri, J.D.; Ugalde-Olano, A.; Loizaga-Iriarte, A.; Santos-MartÃn, A.; Pérez-Fernández, A.; Angulo, J.C.; López, J.I.
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy. Int. J. Mol. Sci. 2024, 25, 1499.
https://doi.org/10.3390/ijms25031499
AMA Style
Larrinaga G, Valdivia A, Arrieta-Aguirre I, Solano-Iturri JD, Ugalde-Olano A, Loizaga-Iriarte A, Santos-MartÃn A, Pérez-Fernández A, Angulo JC, López JI.
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy. International Journal of Molecular Sciences. 2024; 25(3):1499.
https://doi.org/10.3390/ijms25031499
Chicago/Turabian Style
Larrinaga, Gorka, Asier Valdivia, Inés Arrieta-Aguirre, Jon Danel Solano-Iturri, Aitziber Ugalde-Olano, Ana Loizaga-Iriarte, Aida Santos-MartÃn, Amparo Pérez-Fernández, Javier C. Angulo, and José I. López.
2024. "The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy" International Journal of Molecular Sciences 25, no. 3: 1499.
https://doi.org/10.3390/ijms25031499
APA Style
Larrinaga, G., Valdivia, A., Arrieta-Aguirre, I., Solano-Iturri, J. D., Ugalde-Olano, A., Loizaga-Iriarte, A., Santos-MartÃn, A., Pérez-Fernández, A., Angulo, J. C., & López, J. I.
(2024). The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy. International Journal of Molecular Sciences, 25(3), 1499.
https://doi.org/10.3390/ijms25031499
